LATEST ALERTS
The Jamaican government has announced economic support for small-scale medicinal cannabis producers to assuage industry members angered by a recent permit allowing cannabis imports from Canada
A hemp industry under threat, a recreational cannabis market in limbo, and an uncertain political climate have left the future of cannabis in Virginia unclear and many grappling with the fallout of recent legal activity
Key cannabis industry players in the US have scaled back their businesses this year, citing the “challenges of the current market”
A firm that was granted permission to grow and make products from industrial hemp in Mexico was immediately warned by regulators that they would appeal against their own decision
US cannabis operator Ayr Wellness saw good numbers last year helped by cost-saving measures, stepping back from markets that did not align with its business goals, and investing in other different markets
HHC is the most popular intoxicating hemp-derived cannabinoid (IHDC) in Europe, while delta-8 THC remains top in the US, according to CannIntelligence analysts
US cannabis company Trulieve surpassed $1bn in revenue last year, it announced during the release of its 2022 fourth-quarter and full-year results
US-based 22nd Century’s cannabinoid division saw 19% quarterly revenue growth in the fourth quarter of 2022 despite a November fire disrupting operations at a California facility
Canadian cannabis producer Cronos Group saw overall reduced losses for the year, with results helped by sales growth in Canada and Israel but hindered by lower sales in the US
“The lack of progress regarding cannabis regulation from our elected officials in Congress is mind-numbing,” Green Thumb founder, chairman and CEO Ben Kovler said when reporting the company’s results for 2022
Heritage Cannabis enjoyed more than doubled its revenue for the year ended October 2022, despite the challenging regulatory environment in the US
US cannabis company Unrivaled Brands recorded a positive performance in 2022 and plans to expand its cannabis retail footprint across its home state of California
The US Drug Enforcement Administration (DEA) has clarified its position on two synthetic hemp derivatives, confirming that it considers delta-8 THCO and delta-9 THCO illegal
Twitter’s recently announced “change” in the social media platform’s policy to allow cannabis advertisements in the US is full of sound but signifies nothing
Argentina has taken another step towards establishing a national cannabis industry – though not fast enough to satisfy a large number of potential members eager to get on with it
Amid increased criticism, members of Costa Rica’s presidential ministry will modify elements of its recreational cannabis bill prior to seeking its advancement in the country’s 57-member Legislative Assembly
Cannabis companies are looking to get Google certification as part of the tech giant’s update on the use of Google Ads for CBD products in parts of the US
Deference to law enforcement and a history pitted in racism are among the reasons behind South Carolina’s resistance towards legalising medical cannabis, according to activists in the state
US cannabis firm Curaleaf has denied having any secret financial ties to the Russian billionaire Roman Abramovich, who has been sanctioned in the UK and EU since the outbreak of the war in Ukraine
British CBD and hemp brand Voyager has facilitated easier access to the EU market by acquiring a CBD extraction and manufacturing facility in Poland for £1.5m (€1.69m)
Mexican CBD shop Paradise says it has placed itself in prime position for the creation of a legal recreational cannabis market in the country
The European Food Safety Authority denies it is waiting research results on the safety of CBD by the US Food and Drug Administration before it lets validated candidates complete the novel food application process
US company 22nd Century Group has acquired privately held UK cannabinoid distributor RX Pharmatech for an up-front payment of $650,000 in cash and stock
The US Food and Drug Administration (FDA) has issued a final guidance document for the development of medical drugs containing cannabis
The US Food and Drug Administration (FDA) has rejected a regulatory pathway that would allow CBD products to be treated as food additives or dietary supplements
Government and industry representatives from around the world met in Geneva last week to hear about the “significant economic opportunities” offered by industrial hemp and the need for greater clarity on its legal status
Licensed medical cannabis patients in the US state of Georgia can legally possess oils with less than 5% THC, but they can’t legally buy it due to legislative delays and a series of legal appeals
Legislation to create a medical cannabis programme in the US state of Kansas appeared to be on the verge of success many times – but it died again as the 2022 session drew to a close
The US Food and Drug Administration (FDA) may soon issue recommendations for a long-awaited regulation of CBD products in the country
CannIntelligence reviews developments in cannabis regulation in Latin America in 2022 and looks forward to likely further opening-up of the industry in many of the region’s nations in 2023
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
